Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cuneo

Showing results (91-100 of 185) with videos related to

Pageof 19
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 19, 2017
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemiaPier Paolo Piccaluga, Claudio Agostinelli, Simona Righi, et al.
Leukemia & Lymphoma|January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 casesLuigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
Frontiers in Oncology|May 3, 2021
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic LeukemiaMaria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, et al.
Journal of Translational Medicine|June 22, 2018
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patientsSerena De Matteis, Chiara Molinari, Giulia Abbati, et al.
Scientific Reports|May 26, 2016
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and deathErica Salaro, Alessia Rambaldi, Simonetta Falzoni, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Blood|December 31, 2005
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective studyRoberto Cairoli, Alessandro Beghini, Giovanni Grillo, et al.
Journal of Hematology & Oncology|September 17, 2016
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlationsGian Matteo Rigolin, Elena Saccenti, Cristian Bassi, et al.
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Pageof 19

Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 19, 2017
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemiaPier Paolo Piccaluga, Claudio Agostinelli, Simona Righi, et al.
Leukemia & Lymphoma|January 24, 2004
The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 casesLuigi Rigacci, Massimo Federico, Maurizio Martelli, et al.
Frontiers in Oncology|May 3, 2021
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic LeukemiaMaria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, et al.
Journal of Translational Medicine|June 22, 2018
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patientsSerena De Matteis, Chiara Molinari, Giulia Abbati, et al.
Scientific Reports|May 26, 2016
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and deathErica Salaro, Alessia Rambaldi, Simonetta Falzoni, et al.
British Journal of Haematology|December 14, 2011
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patientsAgostino Cortelezzi, Giuseppe Gritti, Luca Laurenti, et al.
Haematologica|March 15, 2006
The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trialGiuseppe Cimino, Fabrizio Pane, Loredana Elia, et al.
Blood|December 31, 2005
Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective studyRoberto Cairoli, Alessandro Beghini, Giovanni Grillo, et al.
Journal of Hematology & Oncology|September 17, 2016
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlationsGian Matteo Rigolin, Elena Saccenti, Cristian Bassi, et al.
Oncotarget|December 17, 2013
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patientsGian Matteo Rigolin, Elena Saccenti, Lara Rizzotto, et al.
Pageof 19